Research
Topics Publications In progress publications CommunicationsPackages
AnaQol Project PRO-online R Packages Online R-packageLife of the unit
Projects Collaborations PhD thesis Traineeships Traineeships propositions SeminarsNext seminars
Last publications
01 décembre 2020
17 novembre 2020
02 octobre 2020
02 septembre 2020
29 août 2020
Updated
17 décembre 2020Edouard Laforgue
Situation
Poste :
Publications scientifiques
Articles dans une revue internationale
- 1.
Jobert A ,Laforgue E ,Grall-Bronnec M ,Rousselet M ,Pere M ,Jolliet P ,FAN network ,Feuillet F ,Victorri-Vigneau C (2020) Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients? European journal of clinical pharmacology. Eur J Clin Pharmacol: Online. - 2.
Victorri-Vigneau C ,Laforgue E ,Grall-Bronnec M ,Guillou-Landreat M ,Rousselet M ,Guerlais M ,Feuillet F ,Jolliet P ,FAN network (2020) Are seniors dependent on benzodiazepines? A national clinical survey of substance use disorder . Clinical Pharmacology and Therapeutics: . - 3.
Schreck B ,Guerlais M ,Laforgue E ,Bichon C ,Grall-Bronnec M ,Victorri-Vigneau C (2020) Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges . Frontiers in Psychiatry, 11: 705. - 4.
Verholleman A ,Victorri-Vigneau C ,Laforgue E ,Derkinderen P ,Verstuyft C ,Grall-Bronnec M (2020) Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness.. International Journal of Molecular Sciences, 21(8): . - 5.
Grall-Bronnec M ,Laforgue E ,Challet G ,CHOLET J ,Leboucher J ,OPAL Group ,Guillou-Landreat M ,Victorri-Vigneau C (2019) Prevalence of co-addictions and rate of successful treatment among a French sample of opioid dependent patients with long-term Opioid Substitution Therapy: the OPAL study. Frontiers in Psychiatry, 10: 726. - 6.
Victorri-Vigneau C ,Verstuyft C ,Bouquié R ,Laforgue E ,Hardouin JB ,Leboucher J ,Le Geay B ,Dano C ,Challet G ,Grall-Bronnec M (2019) Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study. British Journal of Clinical Pharmacology, 85(7): 1538-1543. - 7.
Bulteau S ,Laforgue E ,Chimot L ,Dumont R ,Loutrel O ,Etcheverrigaray F ,Victorri-Vigneau C ,Massri A ,Vanelle J ,Sauvaget A Management of Emergency Electroconvulsive Therapy in the Intensive Care Unit for Life-Threatening Psychiatric Conditions: A Case Series.. J ECT: 55-59.
Articles dans une revue nationale
- 1.
Laforgue E ,Bulteau S ,Cholet J ,Victorri-Vigneau C ,Guitteny M ,Mauduit N ,Vanelle J ,Sauvaget A [Concordance between hospital prescriptions and recommendations in the treatment of mania].. Therapie: 327-337.
Stage dans l'équipe
Communications scientifiques
Communications orales dans un colloque national (idpers=1923)
- 1.
Victorri-Vigneau C. , Verstuyft C. , Laforgue E. , Bouquié R. , Hardouin J.B. , Leboucher J. , Challet G. , Grall-Bronnec M. Impact du polymorphisme du CYP2B6 sur la pharmacocinétique et la réponse clinique de sujets recevant de la méthadone. 10es Ateliers de pharmacodépendance et addictovigilance, Biarritz 15-16 octobre 2018, Thérapie, 2018, 73(6): 563, 2018.